AU2009231601B2 - Methods and systems for glucose regulation - Google Patents

Methods and systems for glucose regulation Download PDF

Info

Publication number
AU2009231601B2
AU2009231601B2 AU2009231601A AU2009231601A AU2009231601B2 AU 2009231601 B2 AU2009231601 B2 AU 2009231601B2 AU 2009231601 A AU2009231601 A AU 2009231601A AU 2009231601 A AU2009231601 A AU 2009231601A AU 2009231601 B2 AU2009231601 B2 AU 2009231601B2
Authority
AU
Australia
Prior art keywords
nerve
electrical signal
vagus nerve
activity
time
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2009231601A
Other languages
English (en)
Other versions
AU2009231601A1 (en
AU2009231601A2 (en
Inventor
Dennis Dong-Won Kim
Mark B. Knudson
Arnold W. Thornton
Katherine S. Tweden
Richard R. Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vyome Holdings Inc
Original Assignee
Reshape Lifesciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reshape Lifesciences Inc filed Critical Reshape Lifesciences Inc
Publication of AU2009231601A1 publication Critical patent/AU2009231601A1/en
Assigned to ENTEROMEDICS INC. reassignment ENTEROMEDICS INC. Amend patent request/document other than specification (104) Assignors: ENTEROMEDICS, INC.
Publication of AU2009231601A2 publication Critical patent/AU2009231601A2/en
Application granted granted Critical
Publication of AU2009231601B2 publication Critical patent/AU2009231601B2/en
Priority to AU2014202313A priority Critical patent/AU2014202313B2/en
Priority to AU2016201492A priority patent/AU2016201492B2/en
Assigned to RESHAPE LIFESCIENCES, INC. reassignment RESHAPE LIFESCIENCES, INC. Request to Amend Deed and Register Assignors: ENTEROMEDICS INC.
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36053—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for vagal stimulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36146—Control systems specified by the stimulation parameters
    • A61N1/36167—Timing, e.g. stimulation onset
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37211—Means for communicating with stimulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37211—Means for communicating with stimulators
    • A61N1/37235—Aspects of the external programmer

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Electrotherapy Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AU2009231601A 2008-04-04 2009-04-03 Methods and systems for glucose regulation Ceased AU2009231601B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2014202313A AU2014202313B2 (en) 2008-04-04 2014-04-29 Methods and systems for glucose regulation
AU2016201492A AU2016201492B2 (en) 2008-04-04 2016-03-08 Methods and systems for glucose regulation

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4257508P 2008-04-04 2008-04-04
US61/042,575 2008-04-04
PCT/US2009/039420 WO2009124233A1 (en) 2008-04-04 2009-04-03 Methods and systems for glucose regulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2014202313A Division AU2014202313B2 (en) 2008-04-04 2014-04-29 Methods and systems for glucose regulation

Publications (3)

Publication Number Publication Date
AU2009231601A1 AU2009231601A1 (en) 2009-10-08
AU2009231601A2 AU2009231601A2 (en) 2010-11-04
AU2009231601B2 true AU2009231601B2 (en) 2014-02-27

Family

ID=40718529

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009231601A Ceased AU2009231601B2 (en) 2008-04-04 2009-04-03 Methods and systems for glucose regulation

Country Status (7)

Country Link
US (5) US8483830B2 (cg-RX-API-DMAC7.html)
EP (2) EP2300099A1 (cg-RX-API-DMAC7.html)
JP (4) JP5486588B2 (cg-RX-API-DMAC7.html)
CN (2) CN105031811B (cg-RX-API-DMAC7.html)
AU (1) AU2009231601B2 (cg-RX-API-DMAC7.html)
HK (1) HK1217306A1 (cg-RX-API-DMAC7.html)
WO (1) WO2009124233A1 (cg-RX-API-DMAC7.html)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
DK2049081T3 (da) 2006-08-09 2013-02-25 Intarcia Therapeutics Inc Osmotiske leveringssystemer og stempelarrangementer
PL2157967T3 (pl) 2007-04-23 2013-06-28 Intarcia Therapeutics Inc Formulacje zawiesinowe peptydów insulinotropowych i ich zastosowania
US8391970B2 (en) * 2007-08-27 2013-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
WO2009146030A1 (en) 2008-03-31 2009-12-03 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of t-cell activity
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
CN105031811B (zh) 2008-04-04 2017-09-08 安特罗麦迪克斯公司 用于葡萄糖调节的方法和系统
WO2010006341A1 (en) * 2008-07-11 2010-01-14 Gep Technology, Inc. Apparatus and methods for minimally invasive obesity treatment
US8255057B2 (en) 2009-01-29 2012-08-28 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
ES2452484T3 (es) 2008-11-18 2014-04-01 Setpoint Medical Corporation Dispositivos para optimizar la colocación de electrodos para la estimulación antiinflamatoria
CA2758944C (en) 2009-04-22 2023-03-14 Konstantinos Alataris Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods
US8788034B2 (en) 2011-05-09 2014-07-22 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US8996116B2 (en) * 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
EP2440284B1 (en) 2009-06-09 2018-09-12 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
NZ598686A (en) 2009-09-28 2014-05-30 Intarcia Therapeutics Inc Rapid establishment and/or termination of substantial steady-state drug delivery
WO2014169145A1 (en) 2013-04-10 2014-10-16 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
EP2515996B1 (en) 2009-12-23 2019-09-18 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
US8825164B2 (en) * 2010-06-11 2014-09-02 Enteromedics Inc. Neural modulation devices and methods
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US12172017B2 (en) 2011-05-09 2024-12-24 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
AU2012304370B2 (en) 2011-09-08 2016-01-28 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
JP6441679B2 (ja) 2011-12-09 2018-12-19 メタベンション インコーポレイテッド 肝臓系の治療的な神経調節
JP6132856B2 (ja) * 2012-03-07 2017-05-24 エンテロメディクス インコーポレイテッド 血圧および心拍数の調節のためのデバイス
WO2013134543A1 (en) 2012-03-08 2013-09-12 Medtronic Ardian Luxembourg Sarl Immune system neuromodulation and associated systems and methods
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US9536449B2 (en) 2013-05-23 2017-01-03 Medibotics Llc Smart watch and food utensil for monitoring food consumption
US9254099B2 (en) 2013-05-23 2016-02-09 Medibotics Llc Smart watch and food-imaging member for monitoring food consumption
US9442100B2 (en) 2013-12-18 2016-09-13 Medibotics Llc Caloric intake measuring system using spectroscopic and 3D imaging analysis
US9042596B2 (en) 2012-06-14 2015-05-26 Medibotics Llc Willpower watch (TM)—a wearable food consumption monitor
US8504161B1 (en) * 2012-08-07 2013-08-06 Medtronic, Inc. Modulate vagal signals to reduce inflammation
US9662445B2 (en) 2012-08-30 2017-05-30 Medtronic Minimed, Inc. Regulating entry into a closed-loop operating mode of an insulin infusion system
US9878096B2 (en) 2012-08-30 2018-01-30 Medtronic Minimed, Inc. Generation of target glucose values for a closed-loop operating mode of an insulin infusion system
US10496797B2 (en) 2012-08-30 2019-12-03 Medtronic Minimed, Inc. Blood glucose validation for a closed-loop operating mode of an insulin infusion system
JP6073478B2 (ja) * 2012-08-30 2017-02-01 メドトロニック ミニメド インコーポレイテッド インスリン注入デバイスを制御するシステム及び方法
US10130767B2 (en) 2012-08-30 2018-11-20 Medtronic Minimed, Inc. Sensor model supervisor for a closed-loop insulin infusion system
US20140066884A1 (en) 2012-08-30 2014-03-06 Medtronic Minimed, Inc. Sensor model supervisor for a closed-loop insulin infusion system
CA2899634A1 (en) * 2013-01-28 2014-07-31 Enteromedics Inc. Energy efficient neuromodulation
US9529385B2 (en) 2013-05-23 2016-12-27 Medibotics Llc Smart watch and human-to-computer interface for monitoring food consumption
WO2014197625A1 (en) 2013-06-05 2014-12-11 Metavention, Inc. Modulation of targeted nerve fibers
US9895539B1 (en) 2013-06-10 2018-02-20 Nevro Corp. Methods and systems for disease treatment using electrical stimulation
AU2014318413B2 (en) 2013-09-16 2019-07-11 The Board Of Trustees Of The Leland Stanford Junior University Multi-element coupler for generation of electromagnetic energy
US10149978B1 (en) 2013-11-07 2018-12-11 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
US20160336813A1 (en) 2015-05-15 2016-11-17 NeuSpera Medical Inc. Midfield coupler
EP3294173B1 (en) 2014-05-18 2020-07-15 Neuspera Medical Inc. Midfield coupler
CN104147699A (zh) * 2014-07-31 2014-11-19 李军 一种用于治疗2型糖尿病的腹腔神经丛电刺激系统
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11577080B2 (en) * 2014-11-03 2023-02-14 Presidio Medical, Inc. Neuromodulation device and method for treating metabolic disorders
WO2016090175A1 (en) 2014-12-03 2016-06-09 Metavention, Inc. Systems and methods for modulating nerves or other tissue
US11406833B2 (en) 2015-02-03 2022-08-09 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
HK1246712A1 (zh) 2015-02-20 2018-09-14 The Feinstein Institute For Medical Research 神经刺激治疗疾病及病症
US9872985B2 (en) 2015-03-03 2018-01-23 Georgia Tech Research Corporation Glucose regulation via electrical stimulation of nerves innervating the liver
AU2016270984B2 (en) 2015-06-03 2021-02-25 Intarcia Therapeutics, Inc. Implant placement and removal systems
JP2017000437A (ja) * 2015-06-10 2017-01-05 オリンパス株式会社 心筋再生装置
US11318310B1 (en) 2015-10-26 2022-05-03 Nevro Corp. Neuromodulation for altering autonomic functions, and associated systems and methods
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
US10695569B2 (en) 2016-01-20 2020-06-30 Setpoint Medical Corporation Control of vagal stimulation
EP3405255B1 (en) 2016-01-20 2025-12-31 Setpoint Medical Corporation IMPLANTABLE MICROSTIMULATORS AND INDUCTION CHARGING SYSTEMS
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
WO2017132174A1 (en) 2016-01-25 2017-08-03 Nevro Corp. Treatment of congestive heart failure with electrical stimulation, and associated systems and methods
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
US10981007B2 (en) 2016-05-13 2021-04-20 Georgia Tech Research Corporation Systems, methods, and devices for neuromodulation
MA53353A (fr) 2016-05-16 2021-06-09 Intarcia Therapeutics Inc Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
US10524859B2 (en) 2016-06-07 2020-01-07 Metavention, Inc. Therapeutic tissue modulation devices and methods
US9955882B2 (en) 2016-08-31 2018-05-01 Medtronic Xomed, Inc. System to monitor neural integrity
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
EP3612083B8 (en) 2017-04-20 2022-12-28 The Feinstein Institutes for Medical Research Systems and methods for real-time monitoring of physiological biomarkers through nerve signals and uses thereof
US11173307B2 (en) 2017-08-14 2021-11-16 Setpoint Medical Corporation Vagus nerve stimulation pre-screening test
JP7404254B2 (ja) * 2018-03-09 2023-12-25 ゼネラル・エレクトリック・カンパニイ 超音波ニューロモジュレーション技術
BR112020020849A2 (pt) * 2018-04-12 2021-01-19 Reshape Lifesciences, Inc. Neuromodulação de nervo vago de múltiplos locais simultâneos para sistemas e métodos de controle glicêmico aperfeiçoados
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
US11590352B2 (en) 2019-01-29 2023-02-28 Nevro Corp. Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods
WO2020168136A1 (en) * 2019-02-13 2020-08-20 Avent, Inc Portable electrical stimulation system and method
CN113939334A (zh) 2019-04-12 2022-01-14 赛博恩特医疗器械公司 迷走神经刺激来处理神经退行性障碍
CN110064130A (zh) * 2019-04-17 2019-07-30 上海黎欧生物科技有限公司 一种胆囊起搏器
WO2020214982A1 (en) * 2019-04-18 2020-10-22 Reshape Lifesciences, Inc. Methods and systems for neural regulation
IL298193B2 (en) 2020-05-21 2024-01-01 Feinstein Institutes For Medical Research Systems and methods for vagus nerve stimulation
WO2022212646A1 (en) * 2021-04-01 2022-10-06 Reshape Lifesciences, Inc. Neuromodulation system and methods for the treatment of a hypoglycemic state
WO2022245878A1 (en) 2021-05-17 2022-11-24 Setpoint Medical Corporation Neurostimulation parameter authentication and expiration system for neurostimulation
US20230355980A1 (en) * 2022-05-05 2023-11-09 Medtronic, Inc. Systems and methods for wirelessly stimulating or blocking at least one nerve

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060190053A1 (en) * 2002-03-22 2006-08-24 Dobak John D Iii Neural stimulation for treatment of metabolic syndrome and type 2 diabetes
US20070027484A1 (en) * 2005-07-28 2007-02-01 Cyberonics, Inc. Autonomic nerve stimulation to treat a pancreatic disorder
WO2009102969A1 (en) * 2008-02-14 2009-08-20 Enteromedics, Inc. Treatment of excess weight by neural downregulation in combination with compositions

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231988A (en) * 1991-08-09 1993-08-03 Cyberonics, Inc. Treatment of endocrine disorders by nerve stimulation
US5540730A (en) 1995-06-06 1996-07-30 Cyberonics, Inc. Treatment of motility disorders by nerve stimulation
US7599736B2 (en) 2001-07-23 2009-10-06 Dilorenzo Biomedical, Llc Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease
US20040249421A1 (en) * 2000-09-13 2004-12-09 Impulse Dynamics Nv Blood glucose level control
IL129032A (en) 1999-03-17 2006-12-31 Moshe Dudai Stomach strap
US6885888B2 (en) 2000-01-20 2005-04-26 The Cleveland Clinic Foundation Electrical stimulation of the sympathetic nerve chain
US6677298B2 (en) * 2000-07-20 2004-01-13 Bristol-Myers Squibb Company Regulators of PPARδ (β) and their use in the treatment of obesity and insulin resistance
US6832114B1 (en) 2000-11-21 2004-12-14 Advanced Bionics Corporation Systems and methods for modulation of pancreatic endocrine secretion and treatment of diabetes
US7167751B1 (en) 2001-03-01 2007-01-23 Advanced Bionics Corporation Method of using a fully implantable miniature neurostimulator for vagus nerve stimulation
US7702394B2 (en) 2001-05-01 2010-04-20 Intrapace, Inc. Responsive gastric stimulator
US6928320B2 (en) 2001-05-17 2005-08-09 Medtronic, Inc. Apparatus for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated
US20060116736A1 (en) 2001-07-23 2006-06-01 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of obesity
US7239912B2 (en) 2002-03-22 2007-07-03 Leptos Biomedical, Inc. Electric modulation of sympathetic nervous system
US7702386B2 (en) 2002-03-22 2010-04-20 Leptos Biomedical, Inc. Nerve stimulation for treatment of obesity, metabolic syndrome, and Type 2 diabetes
US7689276B2 (en) 2002-09-13 2010-03-30 Leptos Biomedical, Inc. Dynamic nerve stimulation for treatment of disorders
EP1551499A1 (en) 2002-10-04 2005-07-13 Microchips, Inc. Medical device for neural stimulation and controlled drug delivery
US7167750B2 (en) 2003-02-03 2007-01-23 Enteromedics, Inc. Obesity treatment with electrically induced vagal down regulation
US20040172084A1 (en) 2003-02-03 2004-09-02 Knudson Mark B. Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)
US7613515B2 (en) * 2003-02-03 2009-11-03 Enteromedics Inc. High frequency vagal blockage therapy
US7844338B2 (en) 2003-02-03 2010-11-30 Enteromedics Inc. High frequency obesity treatment
US7620454B2 (en) 2003-05-19 2009-11-17 Medtronic, Inc. Gastro-electric stimulation for reducing the acidity of gastric secretions or reducing the amounts thereof
US7149574B2 (en) 2003-06-09 2006-12-12 Palo Alto Investors Treatment of conditions through electrical modulation of the autonomic nervous system
US7502649B2 (en) 2003-06-20 2009-03-10 Metacure Ltd. Gastrointestinal methods and apparatus for use in treating disorders
CN1856338B (zh) 2003-07-21 2012-11-14 超治疗有限公司 用于治疗疾病和控制血糖的胃肠方法和装置
US20070060971A1 (en) * 2003-07-21 2007-03-15 Ofer Glasberg Hepatic device for treatment or glucose detection
US7711432B2 (en) * 2004-07-26 2010-05-04 Advanced Neuromodulation Systems, Inc. Stimulation system and method for treating a neurological disorder
US8214047B2 (en) 2004-09-27 2012-07-03 Advanced Neuromodulation Systems, Inc. Method of using spinal cord stimulation to treat gastrointestinal and/or eating disorders or conditions
US7734340B2 (en) 2004-10-21 2010-06-08 Advanced Neuromodulation Systems, Inc. Stimulation design for neuromodulation
US20060122099A1 (en) * 2004-12-08 2006-06-08 Aoki Thomas T Method for infusing insulin to a subject to improve impaired total body tissue glucose processing
CN101124012B (zh) * 2004-12-27 2012-09-05 范因斯坦医学研究院 通过电刺激迷走神经治疗炎症性疾病的装置
US8260426B2 (en) 2008-01-25 2012-09-04 Cyberonics, Inc. Method, apparatus and system for bipolar charge utilization during stimulation by an implantable medical device
WO2006087712A2 (en) 2005-02-17 2006-08-24 Metacure N.V. Charger with data transfer capabilities
US7561923B2 (en) 2005-05-09 2009-07-14 Cardiac Pacemakers, Inc. Method and apparatus for controlling autonomic balance using neural stimulation
US20070016262A1 (en) * 2005-07-13 2007-01-18 Betastim, Ltd. Gi and pancreatic device for treating obesity and diabetes
US7620455B2 (en) 2005-10-25 2009-11-17 Cyberonics, Inc. Cranial nerve stimulation to treat eating disorders
US8041428B2 (en) 2006-02-10 2011-10-18 Electrocore Llc Electrical stimulation treatment of hypotension
CN101674862A (zh) * 2005-11-10 2010-03-17 电子核心公司 支气管收缩的电刺激治疗
JP5108787B2 (ja) * 2006-01-23 2012-12-26 リハブトロニクス インコーポレイテッド 埋め込まれた受動導体を介して電流を体組織へルーティングする方法
WO2007092330A1 (en) 2006-02-03 2007-08-16 Synecor, Llc Intravascular device for neuromodulation
EP1984064A4 (en) 2006-02-10 2009-11-11 Electrocore Inc METHODS AND APPARATUS USED TO TREAT ANAPHYLAXIS USING ELECTRICAL MODULATION
US8187297B2 (en) 2006-04-19 2012-05-29 Vibsynt, Inc. Devices and methods for treatment of obesity
US8160709B2 (en) 2006-05-18 2012-04-17 Endostim, Inc. Use of electrical stimulation of the lower esophageal sphincter to modulate lower esophageal sphincter pressure
US8634930B2 (en) 2006-06-30 2014-01-21 Cardiac Pacemakers, Inc. System for providing diabetic therapy
US8068918B2 (en) 2007-03-09 2011-11-29 Enteromedics Inc. Remote monitoring and control of implantable devices
US20080281365A1 (en) 2007-05-09 2008-11-13 Tweden Katherine S Neural signal duty cycle
US20080300648A1 (en) 2007-05-31 2008-12-04 Pacesetter, Inc. Treatment of cardiomyopathy, heart failure and cardiac ischemia using stimulation induced secretion of glp-1
US20080300647A1 (en) 2007-05-31 2008-12-04 Pacesetter, Inc. Treatment of cardiomyopathy, heart failure and cardiac ischemia using stimulation induced secretion of glp-1
US20080300657A1 (en) 2007-05-31 2008-12-04 Mark Raymond Stultz Therapy system
US20080300645A1 (en) 2007-05-31 2008-12-04 Pacesetter, Inc. Treatment of cardiomyopathy, heart failure and cardiac ischemia using stimulation induced secretion of glp-1
US20080300646A1 (en) 2007-05-31 2008-12-04 Pacesetter, Inc. Treatment of cardiomyopathy, heart failure and cardiac ischemia using stimulation induced secretion of glp-1
WO2009064408A1 (en) 2007-11-12 2009-05-22 Dilorenzo Daniel J Method and apparatus for programming of autonomic neuromodulation for the treatment of obesity
CN105031811B (zh) 2008-04-04 2017-09-08 安特罗麦迪克斯公司 用于葡萄糖调节的方法和系统
US20090254133A1 (en) 2008-04-07 2009-10-08 Wendell Keith F Method for treatment of diabetes by electrostimulatioin
US8204603B2 (en) 2008-04-25 2012-06-19 Cyberonics, Inc. Blocking exogenous action potentials by an implantable medical device
US20090275997A1 (en) 2008-05-01 2009-11-05 Michael Allen Faltys Vagus nerve stimulation electrodes and methods of use
EP2334374A4 (en) 2008-08-26 2011-12-28 Janssen Biotech Inc STIMULATING THE RELEASE OF A SATIETY HORMONE
US20120053653A1 (en) 2009-05-08 2012-03-01 Universite Libre De Bruxelles Gastrointestinal device
US20120259389A1 (en) 2009-09-21 2012-10-11 Warren Starkebaum Treatment of postprandial hyperglycemia by gastric electrical stimulation
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
CA2800889C (en) 2010-05-27 2018-12-04 Ndi Medical, Llc Waveform shapes for treating neurological disorders optimized for energy efficiency
JP5684384B2 (ja) 2010-07-19 2015-03-11 カーディアック ペースメイカーズ， インコーポレイテッド 迷走神経を刺激するためのシステム
WO2012044472A2 (en) 2010-10-01 2012-04-05 Indiana University Research & Technology Corporation Long term vagal nerve stimulation for therapeutic and diagnostic treatment
WO2012060874A2 (en) 2010-11-01 2012-05-10 Udaya Sankar Devanaboyina Methods for diagnosis and treatment of disorders of the gastrointestinal tract. and apparatus for use therewith
WO2012061608A2 (en) 2010-11-03 2012-05-10 The Cleveland Clinic Foundation Apparatus for energy efficient stimulation
EP2651431B1 (en) 2010-12-17 2018-03-07 Neural Diabetes LLC System and apparatus for control of pancreatic beta cell function to improve glucose homeostatis and insulin production

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060190053A1 (en) * 2002-03-22 2006-08-24 Dobak John D Iii Neural stimulation for treatment of metabolic syndrome and type 2 diabetes
US20070027484A1 (en) * 2005-07-28 2007-02-01 Cyberonics, Inc. Autonomic nerve stimulation to treat a pancreatic disorder
WO2009102969A1 (en) * 2008-02-14 2009-08-20 Enteromedics, Inc. Treatment of excess weight by neural downregulation in combination with compositions

Also Published As

Publication number Publication date
JP2016064151A (ja) 2016-04-28
US10722714B2 (en) 2020-07-28
WO2009124233A1 (en) 2009-10-08
CN102056645B (zh) 2015-07-01
US20090254143A1 (en) 2009-10-08
JP2014087681A (ja) 2014-05-15
JP6140258B2 (ja) 2017-05-31
US8483830B2 (en) 2013-07-09
EP3047874B1 (en) 2022-03-09
US20170021174A1 (en) 2017-01-26
US9974955B2 (en) 2018-05-22
JP5937057B2 (ja) 2016-06-22
US9333340B2 (en) 2016-05-10
EP2300099A1 (en) 2011-03-30
JP2017051810A (ja) 2017-03-16
AU2009231601A1 (en) 2009-10-08
CN102056645A (zh) 2011-05-11
EP3047874A1 (en) 2016-07-27
JP5486588B2 (ja) 2014-05-07
US20130079745A1 (en) 2013-03-28
US20190022393A1 (en) 2019-01-24
US20210046313A1 (en) 2021-02-18
HK1217306A1 (zh) 2017-01-06
JP2011516177A (ja) 2011-05-26
CN105031811A (zh) 2015-11-11
CN105031811B (zh) 2017-09-08
AU2009231601A2 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
US10722714B2 (en) Methods and systems for glucose regulation
US20250295920A1 (en) Simultaneous multi-site vagus nerve neuromodulation for improved glycemic control system and methods
US20160317808A1 (en) Neural modulation devices and methods
US20130237948A1 (en) Devices for regulation of blood pressure and heart rate
AU2016201492B2 (en) Methods and systems for glucose regulation
AU2014202313B2 (en) Methods and systems for glucose regulation
HK1227346B (en) Systems for glucose regulation and methods of making such systems
HK1227346A1 (en) Systems for glucose regulation and methods of making such systems

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 01 OCT 2010

FGA Letters patent sealed or granted (standard patent)
HB Alteration of name in register

Owner name: RESHAPE LIFESCIENCES, INC.

Free format text: FORMER NAME(S): ENTEROMEDICS INC.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired